Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It has been extensively studied for its ability to stimulate the endogenous release of growth hormone (GH) by binding to GHRH receptors in the pituitary. Research has focused on its potential to reduce visceral adipose tissue (VAT), enhance lipid metabolism, and improve body composition.

Tesamorelin has also shown promise in studies related to muscle preservation, cognitive support, and mitochondrial function, particularly in aging and metabolic disease models.

For research use only. Not for human or veterinary use.

Products are provided in lyophilized powder form and require reconstitution prior to use in research or laboratory testing.